RHUMBLINE ADVISERS - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 75 filers reported holding TRANSLATE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$2,251,000
+81.5%
81,740
+8.7%
0.00%
+50.0%
Q1 2021$1,240,000
-16.4%
75,227
-6.6%
0.00%0.0%
Q4 2020$1,484,000
+55.2%
80,542
+14.7%
0.00%
+100.0%
Q3 2020$956,000
-22.4%
70,231
+2.1%
0.00%
-50.0%
Q2 2020$1,232,000
+199.0%
68,753
+66.5%
0.00%
+100.0%
Q1 2020$412,000
+31.2%
41,283
+7.2%
0.00%0.0%
Q4 2019$314,000
-14.7%
38,522
+3.8%
0.00%0.0%
Q3 2019$368,000
-22.0%
37,109
-0.6%
0.00%0.0%
Q2 2019$472,000
+46.1%
37,349
+17.8%
0.00%0.0%
Q1 2019$323,000
+319.5%
31,712
+207.4%
0.00%
Q4 2018$77,00010,3150.00%
Other shareholders
TRANSLATE BIO INC shareholders Q1 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders